Skip Navigation
National Cancer Institute
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
 
OverviewProgramsAccomplishmentsEvent ListingNews and HighlightsPublished Research
 

Roundtable for the Scientific Community

Date: September 13, 2004
Time: 1:00 PM–2:30 PM
Place: Natcher Conference Center, NIH Bethesda

Program Agenda

Welcome and Introduction:

  • Anna Barker, Ph.D., Deputy Director for Advanced Technologies and Strategic Partnerships, National Cancer Institute

Overview

  • Andrew von Eschenbach, M.D., Director, National Cancer Institute

Presentation #1:
Nanotechnology and Cancer Research: Technical and Clinical Perspectives

  • Richard Smalley, Ph.D., Professor of Chemistry, Physics, Astronomy, and Nanotechnology, Rice University
  • Samuel Wickline, M.D., Professor of Medicine, Physics and Biomedical Engineering, Washington University

Presentation #2:
The NCI Alliance for Nanotechnology in Cancer: How It Works

  • Mauro Ferrari, Ph.D., Special Expert to the NCI on Nanotechnology and Professor of Biomedical Engineering, Ohio State University
  • Gregory Downing, D.O., Ph.D., Director, Office of Technology and Industrial Relations, Office of the Director, National Cancer Institute

Presentation # 3:
Moving Forward Safely and Collaboratively

  • Janet Woodcock, M.D., Acting Deputy Commissioner for Operations, U.S. Food and Drug Administration
  • Vicki Colvin, Ph.D., Director of the Center for Biological and Environmental Nanotechnology and Associate Professor of Chemistry, Rice University

Panel Discussion and Q&As